IBDEI08N ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11511,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,11511,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,11511,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,11512,0)
 ;;=V12.03^^69^694^33
 ;;^UTILITY(U,$J,358.3,11512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11512,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,11512,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,11512,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,11513,0)
 ;;=V10.82^^69^694^34
 ;;^UTILITY(U,$J,358.3,11513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11513,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,11513,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,11513,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,11514,0)
 ;;=V10.62^^69^694^36
 ;;^UTILITY(U,$J,358.3,11514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11514,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,11514,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,11514,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,11515,0)
 ;;=V10.63^^69^694^35
 ;;^UTILITY(U,$J,358.3,11515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11515,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,11515,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,11515,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,11516,0)
 ;;=V11.2^^69^694^30
 ;;^UTILITY(U,$J,358.3,11516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11516,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,11516,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,11516,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,11517,0)
 ;;=V15.81^^69^694^46
 ;;^UTILITY(U,$J,358.3,11517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11517,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,11517,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,11517,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,11518,0)
 ;;=V10.43^^69^694^37
 ;;^UTILITY(U,$J,358.3,11518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11518,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,11518,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,11518,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,11519,0)
 ;;=V12.71^^69^694^38
 ;;^UTILITY(U,$J,358.3,11519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11519,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,11519,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,11519,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,11520,0)
 ;;=V10.46^^69^694^39
 ;;^UTILITY(U,$J,358.3,11520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11520,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,11520,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,11520,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,11521,0)
 ;;=V11.0^^69^694^40
 ;;^UTILITY(U,$J,358.3,11521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11521,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,11521,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,11521,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,11522,0)
 ;;=V10.83^^69^694^41
 ;;^UTILITY(U,$J,358.3,11522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11522,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,11522,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,11522,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,11523,0)
 ;;=V15.1^^69^694^42
 ;;^UTILITY(U,$J,358.3,11523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11523,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,11523,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,11523,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,11524,0)
 ;;=V15.82^^69^694^44
 ;;^UTILITY(U,$J,358.3,11524,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11524,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,11524,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,11524,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,11525,0)
 ;;=V12.01^^69^694^43
 ;;^UTILITY(U,$J,358.3,11525,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11525,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,11525,1,5,0)
 ;;=5^Hx Of TB
 ;;^UTILITY(U,$J,358.3,11525,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,11526,0)
 ;;=V13.01^^69^694^31
 ;;^UTILITY(U,$J,358.3,11526,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11526,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,11526,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,11526,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,11527,0)
 ;;=V12.51^^69^694^45
 ;;^UTILITY(U,$J,358.3,11527,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11527,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,11527,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,11527,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,11528,0)
 ;;=V17.89^^69^694^3
 ;;^UTILITY(U,$J,358.3,11528,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11528,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,11528,1,5,0)
 ;;=5^Fam Hx Musculosk Dis
 ;;^UTILITY(U,$J,358.3,11528,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,11529,0)
 ;;=V12.54^^69^694^29
 ;;^UTILITY(U,$J,358.3,11529,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11529,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,11529,1,5,0)
 ;;=5^HX of TIA
 ;;^UTILITY(U,$J,358.3,11529,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,11530,0)
 ;;=V12.54^^69^694^28
 ;;^UTILITY(U,$J,358.3,11530,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11530,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,11530,1,5,0)
 ;;=5^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,11530,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,11531,0)
 ;;=V15.88^^69^694^26
 ;;^UTILITY(U,$J,358.3,11531,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11531,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,11531,1,5,0)
 ;;=5^HX of Falls
 ;;^UTILITY(U,$J,358.3,11531,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,11532,0)
 ;;=V13.59^^69^694^27
 ;;^UTILITY(U,$J,358.3,11532,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11532,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,11532,1,5,0)
 ;;=5^HX of Musculoskletl Dis NEC
 ;;^UTILITY(U,$J,358.3,11532,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,11533,0)
 ;;=V12.04^^69^694^58
 ;;^UTILITY(U,$J,358.3,11533,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11533,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,11533,1,5,0)
 ;;=5^Personal H/O MRSA infection
 ;;^UTILITY(U,$J,358.3,11533,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,11534,0)
 ;;=V62.22^^69^694^61
 ;;^UTILITY(U,$J,358.3,11534,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11534,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,11534,1,5,0)
 ;;=5^Personal H/O Retrn Military Deploy
 ;;^UTILITY(U,$J,358.3,11534,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,11535,0)
 ;;=V13.51^^69^694^59
 ;;^UTILITY(U,$J,358.3,11535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11535,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,11535,1,5,0)
 ;;=5^Personal H/O Pathological FX
 ;;^UTILITY(U,$J,358.3,11535,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,11536,0)
 ;;=V15.51^^69^694^63
 ;;^UTILITY(U,$J,358.3,11536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11536,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,11536,1,5,0)
 ;;=5^Personal H/O Traumatic FX
 ;;^UTILITY(U,$J,358.3,11536,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,11537,0)
 ;;=V15.52^^69^694^62
 ;;^UTILITY(U,$J,358.3,11537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11537,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,11537,1,5,0)
 ;;=5^Personal H/O Traumatic Brain Injury
 ;;^UTILITY(U,$J,358.3,11537,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,11538,0)
 ;;=V70.0^^69^695^2
 ;;^UTILITY(U,$J,358.3,11538,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11538,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,11538,1,5,0)
 ;;=5^Routine Med Exam
 ;;^UTILITY(U,$J,358.3,11538,2)
 ;;=^295590
 ;;^UTILITY(U,$J,358.3,11539,0)
 ;;=V77.91^^69^695^3
 ;;^UTILITY(U,$J,358.3,11539,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11539,1,4,0)
 ;;=4^V77.91
 ;;^UTILITY(U,$J,358.3,11539,1,5,0)
 ;;=5^Screen For High Cholesterol
 ;;^UTILITY(U,$J,358.3,11539,2)
 ;;=Screen for High Cholesterol^322093
 ;;^UTILITY(U,$J,358.3,11540,0)
 ;;=V76.44^^69^695^4
 ;;^UTILITY(U,$J,358.3,11540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11540,1,4,0)
 ;;=4^V76.44
 ;;^UTILITY(U,$J,358.3,11540,1,5,0)
 ;;=5^Screen For Prostate Ca
 ;;^UTILITY(U,$J,358.3,11540,2)
 ;;=Screen for Prostate CA^321548
 ;;^UTILITY(U,$J,358.3,11541,0)
 ;;=V74.5^^69^695^6
 ;;^UTILITY(U,$J,358.3,11541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11541,1,4,0)
 ;;=4^V74.5
 ;;^UTILITY(U,$J,358.3,11541,1,5,0)
 ;;=5^Screening for STD's
 ;;^UTILITY(U,$J,358.3,11541,2)
 ;;=Screening for STD's^295637
 ;;^UTILITY(U,$J,358.3,11542,0)
 ;;=V73.89^^69^695^5
 ;;^UTILITY(U,$J,358.3,11542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11542,1,4,0)
 ;;=4^V73.89
 ;;^UTILITY(U,$J,358.3,11542,1,5,0)
 ;;=5^Screening For Hiv
 ;;^UTILITY(U,$J,358.3,11542,2)
 ;;=^295833
 ;;^UTILITY(U,$J,358.3,11543,0)
 ;;=919.1^^69^696^1
 ;;^UTILITY(U,$J,358.3,11543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11543,1,4,0)
 ;;=4^919.1
 ;;^UTILITY(U,$J,358.3,11543,1,5,0)
 ;;=5^Abrasion, Infected
 ;;^UTILITY(U,$J,358.3,11543,2)
 ;;=^275358
 ;;^UTILITY(U,$J,358.3,11544,0)
 ;;=919.0^^69^696^2
 ;;^UTILITY(U,$J,358.3,11544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11544,1,4,0)
 ;;=4^919.0
 ;;^UTILITY(U,$J,358.3,11544,1,5,0)
 ;;=5^Abrasion, Not Infected
 ;;^UTILITY(U,$J,358.3,11544,2)
 ;;=^1305
 ;;^UTILITY(U,$J,358.3,11545,0)
 ;;=924.9^^69^696^3
 ;;^UTILITY(U,$J,358.3,11545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11545,1,4,0)
 ;;=4^924.9
 ;;^UTILITY(U,$J,358.3,11545,1,5,0)
 ;;=5^Bite, Human, Contusion
 ;;^UTILITY(U,$J,358.3,11545,2)
 ;;=^28117
 ;;^UTILITY(U,$J,358.3,11546,0)
 ;;=879.8^^69^696^4
 ;;^UTILITY(U,$J,358.3,11546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,11546,1,4,0)
 ;;=4^879.8
 ;;^UTILITY(U,$J,358.3,11546,1,5,0)
 ;;=5^Bite, Human, Penetrating
 ;;^UTILITY(U,$J,358.3,11546,2)
 ;;=^275021
 ;;^UTILITY(U,$J,358.3,11547,0)
 ;;=919.3^^69^696^5
